Prelude Therapeutics Incorporated
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
MAURO DAVID J
Common Stock 9,617 $1.89 $18,176
Sale
MAURO DAVID J
Common Stock 9,617 $38.36 $368,860
Option
MAURO DAVID J
Employee Stock Option (right to buy) 9,617 $1.89 $18,176
Option
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Common Stock 100 N/A N/A
Sale
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Common Stock 100 N/A N/A
Sale
SCHERLE PEGGY
Common Stock 4,630 N/A N/A
Option
SCHERLE PEGGY
Employee Stock Option (right to buy) 4,630 N/A N/A
Option
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Employee Stock Option (right to buy) 100 N/A N/A
Sale
PIERCE CHRISTOPHER officer: EVP and Chief of Busin..
 Common Stock 200 N/A N/A
Option
PIERCE CHRISTOPHER officer: EVP and Chief of Busin..
 Employee Stock Option (right to buy) 200 N/A N/A
Sale
MAURO DAVID J
Common Stock 15,383 $39.36 $605,429
Sale
SCHERLE PEGGY
Common Stock 15,370 $39.65 $609,390
Option
MAURO DAVID J
Common Stock 15,383 $1.89 $29,074
Sale
MAURO DAVID J
Common Stock 15,383 N/A N/A
Option
MAURO DAVID J
Employee Stock Option (right to buy) 15,383 $1.89 $29,074
Option
PIERCE CHRISTOPHER officer: EVP and Chief of Busin..
 Employee Stock Option (right to buy) 828 $1.89 $1,565
Option
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Common Stock 1,000 $1.89 $1,890
Sale
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Common Stock 1,000 $1.89 $1,890
Option
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Employee Stock Option (right to buy) 1,000 $1.89 $1,890
Sale
PIERCE CHRISTOPHER officer: EVP and Chief of Busin..
 Common Stock 828 $1.89 $1,565
Sale
SCHERLE PEGGY
Common Stock 15,370 $39.65 $609,390
Option
SCHERLE PEGGY
Employee Stock Option (right to buy) 15,370 N/A N/A
Option
BAKER BROS. ADVISORS LP director, 10 percent owner
 Common Stock 10,376 N/A N/A
Option
BAKER BROS. ADVISORS LP director, 10 percent owner
 Non-Qualified Stock Options (right to buy) 5,188 $12.85 $66,666
Option
BAKER BROS. ADVISORS LP director, 10 percent owner
 Common Stock 10,376 $12.85 $133,332
Purchase
BONITA DAVID P director, 10 percent owner
 Non-Voting Common Stock 41,700 $60 $2,502,000
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Non-Voting Common Stock 41,700 N/A N/A
Purchase
BAKER BROS. ADVISORS LP director, 10 percent owner
 Non-Voting Common Stock 166,666 $30 $4,999,980
Purchase
COMBS ANDREW officer: EVP, Head of Chemistry
 Common Stock 1,000 N/A N/A
Purchase
MOROSINI DEBORAH officer: EVP, Chief of Clinical..
 Common Stock 444 N/A N/A
Purchase
PIERCE CHRISTOPHER officer: EVP and Chief of Busin..
 Common Stock 3,750 N/A N/A
Purchase
BAKER BROS. ADVISORS LP director, 10 percent owner
 Common Stock 1,578,947 N/A N/A
Purchase
DIER MARDI director
 Common Stock 10,000 N/A N/A
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 1,236,800 N/A N/A
Purchase
BONITA DAVID P director, 10 percent owner
 Common Stock 1,236,800 N/A N/A
Purchase
BONITA DAVID P director, 10 percent owner
 Series C Preferred Stock 1,033,084 N/A N/A
Purchase
BAKER BROS. ADVISORS LP director, 10 percent owner
 Series C Preferred Stock 1,033,084 N/A N/A
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Series C Preferred Stock 1,033,084 N/A N/A
Purchase
BAKER BROS. ADVISORS LP director, 10 percent owner
 Series B Preferred Stock 3,681,822 $6.43 $23,655,706
Purchase
BAKER BROS. ADVISORS LP director, 10 percent owner
 Series B Preferred Stock 3,681,822 N/A N/A
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Series B Preferred Stock 3,681,822 N/A N/A
Purchase
FRIEDMAN PAUL A director
 Series B Preferred Stock 76,288 N/A N/A
Purchase
BONITA DAVID P director, 10 percent owner
 Series B Preferred Stock 3,681,822 N/A N/A

Showing 100 to 143 of 143 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: